Skip to Content
Merck
  • Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader.

Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader.

Cell chemical biology (2019-12-14)
Frances Potjewyd, Anne-Marie W Turner, Joshua Beri, Justin M Rectenwald, Jacqueline L Norris-Drouin, Stephanie H Cholensky, David M Margolis, Kenneth H Pearce, Laura E Herring, Lindsey I James
ABSTRACT

Protein degradation via the use of bivalent chemical degraders provides an alternative strategy to block protein function and assess the biological roles of putative drug targets. This approach capitalizes on the advantages of small-molecule inhibitors while moving beyond the restrictions of traditional pharmacology. Here, we report a chemical degrader (UNC6852) that targets polycomb repressive complex 2 (PRC2). UNC6852 contains an EED226-derived ligand and a ligand for VHL which bind to the WD40 aromatic cage of EED and CRL2VHL, respectively, to induce proteasomal degradation of PRC2 components, EED, EZH2, and SUZ12. Degradation of PRC2 with UNC6852 blocks the histone methyltransferase activity of EZH2, decreasing H3K27me3 levels in HeLa cells and diffuse large B cell lymphoma (DLBCL) cells containing EZH2 gain-of-function mutations. UNC6852 degrades both wild-type and mutant EZH2, and additionally displays anti-proliferative effects in this cancer model system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-GAPDH Antibody, from chicken, purified by affinity chromatography